Cellphmed is a bioinformatic platform enabling the discovery and early development of novel diagnostic biomarkers and immunotherapy targets to better treat cancer. Having developed proprietary tools to decipher unexplored regions of the genome (up to 80% encompassing millions of uncharted RNA biomarkers) the company’s vision is to use big data to change the paradigm of oncology in providing the right drug to the right patient at the right time, thereby bringing personalized medicine to the clinic.
Company Details
- Address
- Epfl Innovation Park, Bat. C, Lausanne,vaud 1015,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cellphmed.bio
- Keywords
- Bioinformatics, Transcriptomics, Genetics, Virology, Machine Learning, AI, RNA, RNA biomarkers, Biomarkers, Transposable elements, Transposcriptome, TEs, Oncology, Liquid biopsy, Early detection, Immunotherapy targets, Cancer diagnostics, Cancer therapy, Solid tumour, Biopsy.
- HQ
- Lausanne, Vaud
Cellphmed Questions
Cellphmed's website is http://www.cellphmed.bio
Cellphmed's LinkedIn profile is https://ch.linkedin.com/company/cellphmed
Cellphmed's industry is
Biotechnology Research
Cellphmed's top competitors are
Esperare Foundation,
Bma Biomedicals,
Microfluidic Valley,
Neotherma Oncology,
Widler & Schiemann Ag,
Cis Pharma,
Cellntec Advanced Cell Systems,
Afr Oncology,
Ableads,
Cancer Research And Biotechnology Ag.
Cellphmed's categories are Biotechnology Research
